CKPT Insider Trading Activity and SEC Form 4 Filings
CKPT insider trading summary
No open-market insider purchases or sales of Checkpoint Therapeutics, Inc. (CKPT) have been reported on SEC Form 4 in the past 12 months.
Latest CKPT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 29, 2025 | Fortress Biotech, Inc. | Insider | Sell | $129K (100,000 @ $1.29) |
| Apr 2, 2025 | James F Oliviero III | CEO, President and Director | Sell | $61K (15,090 @ $4.04) |
| Apr 1, 2025 | William Garrett Gray | Chief Financial Officer | Sell | $50K (12,322 @ $4.05) |
| Feb 10, 2025 | James F Oliviero III | CEO, President and Director | Sell | $33K (10,331 @ $3.15) |
| Feb 7, 2025 | James F Oliviero III | CEO, President and Director | Sell | $31K (9,233 @ $3.41) |
| Feb 6, 2025 | William Garrett Gray | Chief Financial Officer | Sell | $272K (74,110 @ $3.67) |
| Dec 19, 2024 | James F Oliviero III | CEO, President and Director | Sell | $744K (220,230 @ $3.38) |
| Dec 18, 2024 | William Garrett Gray | Chief Financial Officer | Sell | $1.1M (268,432 @ $4.01) |
| Dec 18, 2024 | James F Oliviero III | CEO, President and Director | Sell | $2.3M (602,167 @ $3.87) |
| Jun 26, 2024 | William Garrett Gray | Chief Financial Officer | Sell | $27K (13,038 @ $2.06) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.